These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36939575)

  • 1. Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 1: Effects of Polymer and Drug Chiralities.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2023 Apr; 20(4):1861-1871. PubMed ID: 36939575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 2: Effects of Solubilizer.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2023 Apr; 20(4):1872-1883. PubMed ID: 36939568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable-Temperature NMR Analysis of the Thermodynamics of Polymer Partitioning between Aqueous and Drug-Rich Phases and Its Significance for Amorphous Formulations.
    Ueda K; Higashi K; Moribe K; Taylor LS
    Mol Pharm; 2022 Jan; 19(1):100-114. PubMed ID: 34702040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual Correlation between the Apparent Amorphous Solubility of a Drug and Solubilizer Concentration Revealed by NMR Analysis.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2022 Sep; 19(9):3336-3349. PubMed ID: 35924819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy.
    Ueda K; Moseson DE; Pathak V; Taylor LS
    Mol Pharm; 2021 Mar; 18(3):1344-1355. PubMed ID: 33595322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size.
    Ueda K; Taylor LS
    J Control Release; 2021 Feb; 330():229-243. PubMed ID: 33340567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer Type Impacts Amorphous Solubility and Drug-Rich Phase Colloidal Stability: A Mechanistic Study Using Nuclear Magnetic Resonance Spectroscopy.
    Ueda K; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1352-1362. PubMed ID: 32097023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
    Baghel S; Cathcart H; O'Reilly NJ
    Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphous Drug Solubility and Maximum Free Drug Concentrations in Cyclodextrin Solutions: A Quantitative Study Using NMR Diffusometry.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2021 Jul; 18(7):2764-2776. PubMed ID: 34180226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vinylpyrrolidone polymers on the solubility and supersaturation of drugs; a study using the Cheqsol method.
    Fornells E; Fuguet E; Mañé M; Ruiz R; Box K; Bosch E; Ràfols C
    Eur J Pharm Sci; 2018 May; 117():227-235. PubMed ID: 29481859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM; Boyd B; Rades T; Müllertz A
    Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine.
    Zhao P; Hu G; Chen H; Li M; Wang Y; Sun N; Wang L; Xu Y; Xia J; Tian B; Liu Y; He Z; Fu Q
    Int J Pharm; 2022 Mar; 616():121538. PubMed ID: 35124119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-Mediated Drug Supersaturation Controlled by Drug-Polymer Interactions Persisting in an Aqueous Environment.
    Chen Y; Pui Y; Chen H; Wang S; Serno P; Tonnis W; Chen L; Qian F
    Mol Pharm; 2019 Jan; 16(1):205-213. PubMed ID: 30452278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.
    Dahan A; Beig A; Ioffe-Dahan V; Agbaria R; Miller JM
    AAPS J; 2013 Apr; 15(2):347-53. PubMed ID: 23242514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Insight into Different Stabilization Mechanisms of Phenytoin Derivatives Supersaturation by HPMC and PVP.
    Otsuka N; Ueda K; Ohyagi N; Shimizu K; Katakawa K; Kumamoto T; Higashi K; Yamamoto K; Moribe K
    J Pharm Sci; 2015 Aug; 104(8):2574-82. PubMed ID: 26059285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.
    Trasi NS; Taylor LS
    Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
    Peng R; Huang J; He L; Zhao L; Wang C; Wei W; Xia T; Mao Y; Wen Y; Wang L; Yang J
    Eur J Pharm Sci; 2020 Apr; 146():105262. PubMed ID: 32060005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical evaluation of supersaturation of amorphous solid dispersion formulations with different drug/polymer combinations using mathematical modeling.
    Hirai D; Tsunematsu H; Kimura SI; Itai S; Fukami T; Iwao Y
    Int J Pharm; 2022 Sep; 625():122110. PubMed ID: 35970282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.